RCMNY
OCUL icon

Rubric Capital Management (New York)’s Ocular Therapeutix OCUL Stock Holding History

Rubric Capital Management (New York)’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-354,728
Closed -$3.55M – 80
2021
Q3 		$3.55M Sell
354,728
-1,801,814
-84% -$20.2M 0.2% 53
2021
Q2 		$30.6M Buy
2,156,542
+1,774,156
+464% +$27M 1.93% 24
2021
Q1 		$6.28M Buy
+382,386
New +$7.36M 0.37% 52

Other funds holding OCUL

OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DAM
Deltec Asset Management New York $545M AUM 33.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return